Two TP53 germline mutations in a classical Li-Fraumeni syndrome family

By Hest Liselotte   Ruijs Mariëlle   Wagner Anja   Meer Conny   Verhoef Senno   van‘t Veer Laura   Meijers-Heijboer Hanne  

Familial Cancer, Vol. 6, Iss. 3, 2007-09 ,pp. : 311-316

Springer Publishing Company

Access to resources Recommend Favorite

A New Germline TP53 Gene Mutation in a Family With Li-Fraumeni Syndrome

By Dockhorn-Dworniczak B.   Wolff J.   Poremba C.   Schafer K.-L.   Ritter J.   Gullotta F.   Jurgens H.   Bocker W.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1359-1365

Elsevier

Access to resources Recommend Favorite

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

Genotype Phenotype Correlation in Li-Fraumeni Syndrome Kindreds and its Implications for Management

By Moule R.   Jhavar S.   Eeles R.  

Familial Cancer, Vol. 5, Iss. 2, 2006-06 ,pp. : 129-133

Springer Publishing Company

Access to resources Recommend Favorite

Potential of Advexin^®®: a p53 gene-replacement therapy in Li––Fraumeni syndrome

By Nemunaitis Jackie M   Nemunaitis John  

Future Oncology, Vol. 4, Iss. 6, 2008-12 ,pp. : 759-768

Future Medicine

Access to resources Recommend Favorite